M1FG
WVE icon

Mach-1 Financial Group’s Wave Life Sciences WVE Stock Holding History

Mach-1 Financial Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$125K Buy
+21,475
New +$142K 0.05% 125

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Mach-1 Financial Group's WVE Position: Q2 2026 in Review

Mach-1 Financial Group opened a new position in Wave Life Sciences (WVE) in Q2 2026: 21,475 shares worth $125K. The stake represents 0.05% of the portfolio and ranks #125 among its holdings.

239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Mach-1 Financial Group held 21,475 shares of Wave Life Sciences worth $125K as of Q2 2026.
  • Wave Life Sciences was a new Mach-1 Financial Group position in Q2 2026.
  • Wave Life Sciences made up 0.05% of Mach-1 Financial Group's portfolio in Q2 2026, its #125 holding.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Mach-1 Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.